CA2160248A1 - Pharmaceutical composition containing thymoctonan and azt - Google Patents
Pharmaceutical composition containing thymoctonan and aztInfo
- Publication number
- CA2160248A1 CA2160248A1 CA002160248A CA2160248A CA2160248A1 CA 2160248 A1 CA2160248 A1 CA 2160248A1 CA 002160248 A CA002160248 A CA 002160248A CA 2160248 A CA2160248 A CA 2160248A CA 2160248 A1 CA2160248 A1 CA 2160248A1
- Authority
- CA
- Canada
- Prior art keywords
- thymoctonan
- azt
- hiv
- treatment
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Virology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9403856A GB9403856D0 (en) | 1994-03-01 | 1994-03-01 | Combined treatment of human retroviral infections |
| GB9403856.9 | 1994-03-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2160248A1 true CA2160248A1 (en) | 1995-09-08 |
Family
ID=10751061
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002160248A Abandoned CA2160248A1 (en) | 1994-03-01 | 1995-02-23 | Pharmaceutical composition containing thymoctonan and azt |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0696202A1 (fi) |
| JP (1) | JPH08509993A (fi) |
| KR (1) | KR960701652A (fi) |
| AU (1) | AU1759295A (fi) |
| CA (1) | CA2160248A1 (fi) |
| FI (1) | FI955181A0 (fi) |
| GB (1) | GB9403856D0 (fi) |
| HU (1) | HUT73178A (fi) |
| IL (1) | IL112803A0 (fi) |
| MX (1) | MX9504565A (fi) |
| NO (1) | NO954171D0 (fi) |
| PL (1) | PL311340A1 (fi) |
| WO (1) | WO1995023610A1 (fi) |
| ZA (1) | ZA951654B (fi) |
-
1994
- 1994-03-01 GB GB9403856A patent/GB9403856D0/en active Pending
-
1995
- 1995-02-23 MX MX9504565A patent/MX9504565A/es unknown
- 1995-02-23 PL PL95311340A patent/PL311340A1/xx unknown
- 1995-02-23 EP EP95910515A patent/EP0696202A1/en not_active Withdrawn
- 1995-02-23 HU HU9503432A patent/HUT73178A/hu unknown
- 1995-02-23 JP JP7522672A patent/JPH08509993A/ja active Pending
- 1995-02-23 KR KR1019950704771A patent/KR960701652A/ko not_active Application Discontinuation
- 1995-02-23 CA CA002160248A patent/CA2160248A1/en not_active Abandoned
- 1995-02-23 WO PCT/EP1995/000653 patent/WO1995023610A1/en not_active Application Discontinuation
- 1995-02-23 AU AU17592/95A patent/AU1759295A/en not_active Abandoned
- 1995-02-27 IL IL11280395A patent/IL112803A0/xx unknown
- 1995-02-28 ZA ZA951654A patent/ZA951654B/xx unknown
- 1995-10-19 NO NO954171A patent/NO954171D0/no unknown
- 1995-10-30 FI FI955181A patent/FI955181A0/fi not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HUT73178A (en) | 1996-06-28 |
| ZA951654B (en) | 1995-12-08 |
| HU9503432D0 (en) | 1996-01-29 |
| FI955181A (fi) | 1995-10-30 |
| JPH08509993A (ja) | 1996-10-22 |
| NO954171L (no) | 1995-10-19 |
| FI955181A0 (fi) | 1995-10-30 |
| WO1995023610A1 (en) | 1995-09-08 |
| IL112803A0 (en) | 1995-05-26 |
| EP0696202A1 (en) | 1996-02-14 |
| MX9504565A (es) | 1997-05-31 |
| KR960701652A (ko) | 1996-03-28 |
| AU1759295A (en) | 1995-09-18 |
| GB9403856D0 (en) | 1994-04-20 |
| PL311340A1 (en) | 1996-02-05 |
| NO954171D0 (no) | 1995-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Noble et al. | Saquinavir: a review of its pharmacology and clinical potential in the management of HIV infection | |
| JPH11507632A (ja) | 併用療法を用いたｈｉｖおよび他のウイルス感染の治療 | |
| Craig et al. | Antiviral synergy between inhibitors of HIV proteinase and reverse transcriptase | |
| Hammer et al. | Issues in combination antiretroviral therapy: a review | |
| JPH07267874A (ja) | Ｈｉｖ感染に対する組合せ化学療法 | |
| TOCHIKURA et al. | Suppression of human immunodeficiency virus replication by 3'-azido-3'-deoxythymidine in various human hematopoietic cell lines in vitro: augmentation of the effect by lentinan | |
| JP2004538334A (ja) | Ｈｉｖ感染の治療に使用される薬剤とその成分と使用法 | |
| CA2160248A1 (en) | Pharmaceutical composition containing thymoctonan and azt | |
| RU2126266C1 (ru) | Способ ингибирования ретровирусной инфекции (варианты), ингибитор протеазы, кодирующая его нуклеиновая кислота и способ рекомбинантного продуцирования серинового ингибитора | |
| AU2003299085B2 (en) | Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome | |
| Hofmann et al. | Investigation of immunosuppressive properties of inactivated human immunodeficiency virus and possible neutralization of this effect by some patient sera | |
| JP2001520657A (ja) | Ｈｉｖ感染用コンビネーションセラピー | |
| Lambert et al. | Synergistic drug interactions of an HIV-1 protease inhibitor with AZT in different in vitro models of HIV-1 infection | |
| HUT77720A (hu) | HIV-ellenes, zidovudint, lamivudint és loviridint tartalmazó kombinációs gyógyszerkészítmény és eljárás előállítására | |
| Acosta et al. | Agents for treating human immunodeficiency virus infection | |
| EP0684818B1 (en) | Method of reversing resistance of hiv-1 strains to zidovudine | |
| Chirigos et al. | Imexon and biological response modifiers in murine models of AIDS | |
| Pomerantz et al. | Therapy of human immunodeficiency virus infections | |
| HU203971B (en) | Process for producing synergetic combination pharmaceutical compositions comprising 3'-azido-3'-deoxythymidine and one more active ingredient | |
| López-Aldeguer et al. | New targets and new drugs in the treatment of HIV | |
| Youle et al. | 8 The treatment of HIV disease | |
| Chermann et al. | Retroviruses and AIDS | |
| Perno et al. | Cytokines Modulate HIV Replication and the Activity of Antiviral Drugs in Cells of Monocyte/Macrophage Lineage | |
| Fischl | Antiviral therapies for acquired immunodeficiency syndrome and human immunodeficiency virus type 1 infection | |
| EP1523328A2 (en) | Methods and compositions for inhibiting hiv replication |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |